(15R,21S,24S,27S,30S)-15-(2-amino-2-oxoethyl)-1-((S)-1-((S)-2-((S)-1-((R)-2-amino-3-phenylpropanoyl)pyrrolidine-2-carboxamido)-5-guanidinopentanoyl)pyrrolidin-2-yl)-24-benzyl-30-(((2S,3S)-1-((S)-2-(((S)-4-carboxy-1-(((S)-4-carboxy-1-(((S)-1-(((S)-1-carboxy-3-methylbutyl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-1-oxobutan-2-yl)amino)-1-oxobutan-2-yl)carbamoyl)pyrrolidin-1-yl)-3-methyl-1-oxopentan-2-yl)carbamoyl)-27-(2-carboxyethyl)-21-(carboxymethyl)-1,4,7,10,13,16,19,22,25,28-decaoxo-2,5,8,11,14,17,20,23,26,29-decaazatritriacontan-33-oic acid.
Bivalirudin D-Asn Impurity is a fully characterized chemical compound used as a reference standard of API Bivalirudin. The standard offered is compliant with regulatory guidelines. Bivalirudin D-Asn Impurity is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1310025-28-5
![Picture of Bivalirudin Impurity ([Beta-Asp9]-Bivalirudin)](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-B01795.jpg?size=256 "Show details for Bivalirudin Impurity ([Beta-Asp9]-Bivalirudin)")
![Picture of [9,10]-Cyclo Bivalirudin](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-B01802.jpg?size=256 "Show details for [9,10]-Cyclo Bivalirudin")
